FDA waits for Moderna’s emergency use application for COVID-19 vaccines

Spread the love

The Food and Drug Administration is awaiting the emergency use authorization (EUA) application of US drug manufacturer Moderna for its COVID-19 vaccines.

The agency said that it is already looking into the published studies of the brand’s vaccine to expedite the process as Philippine Ambassador to the US Jose Manuel Romualdez announced Moderna’s deployment of 200,000 doses to the country by mid-June.

“Hindi pa rin sila nag-aapply,” FDA Director General Eric Domingo confirmed during a virtual briefing. 

Domingo also said it is helpful that Moderna, unlike other vaccine developers, already have published data in peer-reviewed journals on the COVID-19 vaccine’s safety and efficacy. This will be FDA’s basis on the possibility of expediting Moderna’s EUA in the Philippines.